21 Drugs Are Cleared For Back-End Payments In Revised Pilot Of 340B Program (+++) Morning Briefing

21 Drugs Are Cleared For Back-End Payments In Revised Pilot Of 340B Program Come Jan. 1, 10 pharmaceutical companies will pay rebates to providers only after it's been established that qualifying drugs were dispensed to eligible patients. Drugmakers have expressed concern that there is waste and fraud in the program, an allegation that hospitals say is overblown. https://kffhealthnews.org/morning-breakout/administration-news-100226/ Senate Committee Looks For Ways To Block White House Interference In Medical Research Grants Bipartisan Senate appropriators are looking for language that could be added to the Labor-HHS-Education appropriations bill that lawmakers hope to pass before stopgap funding expires Dec. 11, Roll Call reported. Meanwhile, STAT reported that NIH grants around race and health disparities saw cuts this year. https://kffhealthnews.org/morning-breakout/capitol-watch-100226/ After Botched Execution, Questions Swirl As Tennessee Inmate Receives Lifesaving Care At Vanderbilt Facility Christa Pike told the execution team that she felt burning and pain while they were trying to deliver the lethal drug into her system. Joel Zivot, a professor at Emory University School of Medicine who previously was retained by Pike's legal team as a medical expert, offered a theory that the IV lines failed during the procedure, causing pentobarbital to leak outside the veins rather than fully entering Pike's circulation, Newsweek wrote. Pike's prognosis is unclear. https://kffhealthnews.org/morning-breakout/execution-100226/